文献速递头颈外科

吸烟与肿瘤亚部位对HPV相关口咽鳞癌复发的影响

Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-06-29

这项回顾性观察研究纳入171例2008-2019年接受原发治疗的HPV相关口咽鳞癌患者,分析吸烟状态与肿瘤亚部位对复发风险的影响。结果显示,吸烟与舌根癌复发风险升高相关,而与扁桃体癌复发风险降低相关,提示吸烟可能以亚部位特异的方式影响复发。

要点

  • 舌根癌吸烟者5年无复发生存率低于不吸烟者(P=.001)。
  • 舌根癌吸烟者复发风险高于不吸烟者(aHR 7.36,95%CI 1.61-33.68)。
  • 扁桃体癌吸烟者复发风险低于不吸烟者(aHR 0.23,95%CI 0.06-0.89)。

核心结论

  • 吸烟可能与口咽内肿瘤亚部位独特交互,影响HPV相关口咽鳞癌的复发风险。

研究设计与样本

  • 回顾性观察研究,纳入171例2008-2019年接受原发治疗的HPV相关口咽鳞癌患者。

主要发现

  • 31例(18.1%)发生复发,其中19例为曾经吸烟者。
  • 舌根癌曾经吸烟者复发率为41.7%,从不吸烟者为5.1%;扁桃体癌曾经吸烟者复发率为9.1%,从不吸烟者为19.2%。
  • 舌根癌曾经吸烟者5年无复发生存率低于从不吸烟者(P=.001),扁桃体癌两者无差异(P=.215)。
  • 多变量分析中,舌根癌曾经吸烟者复发风险高于从不吸烟者(aHR 7.36;95%CI 1.61-33.68;P=.010),扁桃体癌曾经吸烟者复发风险低于从不吸烟者(aHR 0.23;95%CI 0.06-0.89;P=.033)。

临床怎么用

  • 评估HPV相关口咽鳞癌复发风险时,可结合吸烟状态与肿瘤亚部位进行个体化分层。
  • 对舌根癌吸烟患者应关注更高复发风险,对扁桃体癌吸烟患者的复发风险解读需谨慎。

局限性

  • 本研究为单中心回顾性观察研究,样本量有限,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe risk of recurrence and recurrence characteristics between ever- and never-smoking patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV+ OPSCC) when stratified by primary tumor subsite. STUDY DESIGN: Retrospective observational study. SETTING: Tertiary care center. METHODS: Retrospective chart review of 171 patients with HPV+ OPSCC with primary treatment between 2008 and 2019. Five-year recurrence-free survival and risk of recurrence were evaluated through Kaplan-Meier curves with log-rank test and Cox proportional hazards models, respectively. RESULTS: Of 171 patients with HPV+ OPSCC, 81.9% were male, and the average age was 63.9 years. Eighty patients (46.8%) had a smoking history (average, 17.7 pack-years), including 4 current smokers. Recurrence occurred in 31 patients (18.1%), 19 of whom were ever smokers. The recurrence rate for ever smokers with primary base of tongue (BOT) cancer was 41.7%, while 5.1% of never smokers with BOT primaries had recurrence. For primary tonsillar disease, 9.1% of ever smokers had recurrence versus 19.2% of never smokers. Five-year recurrence-free survival for BOT primaries was lower in ever smokers than never smokers (P = .001) but did not differ between ever and never smokers for tonsillar primaries (P = .215). In multivariable analysis across this period, ever-smoking status was associated with higher risk of recurrence than never-smoking status in BOT primaries (adjusted hazard ratio, 7.36; 95% CI, 1.61-33.68; P = .010) but with lower risk of recurrence after tonsillar primaries (adjusted hazard ratio, 0.23; 95% CI, 0.06-0.89; P = .033). CONCLUSION: Smoking may uniquely interact with tumor subsites within the oropharynx to influence recurrence risk. Understanding the association between smoking and HPV+ OPSCC recurrence could lead to personalized, evidence-based treatments to improve oncologic outcomes.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lee RH, Salesky M, Benjamin T, et al. Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2021. PMID: 34182836. doi:10.1177/01945998211024515

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。